P750 Stock Overview
Provides products and solutions for use of injectable drugs in Sweden.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Perpetua Medical AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 0.0098 |
| 52 Week High | SEK 0.039 |
| 52 Week Low | SEK 0.0002 |
| Beta | 2.21 |
| 11 Month Change | 206.25% |
| 3 Month Change | 48.48% |
| 1 Year Change | -40.96% |
| 33 Year Change | -98.84% |
| 5 Year Change | n/a |
| Change since IPO | -98.23% |
Recent News & Updates
Recent updates
Shareholder Returns
| P750 | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | 2.1% | 0.5% | -0.1% |
| 1Y | -41.0% | 0.9% | 2.4% |
Return vs Industry: P750 underperformed the German Medical Equipment industry which returned 0.9% over the past year.
Return vs Market: P750 underperformed the German Market which returned 2.4% over the past year.
Price Volatility
| P750 volatility | |
|---|---|
| P750 Average Weekly Movement | 88.6% |
| Medical Equipment Industry Average Movement | 4.4% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.3% |
| 10% least volatile stocks in DE Market | 2.6% |
Stable Share Price: P750's share price has been volatile over the past 3 months.
Volatility Over Time: P750's weekly volatility has decreased from 190% to 89% over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2007 | 4 | Anders Hedlund | perpetuamedical.se |
Perpetua Medical AB (publ) provides products and solutions for use of injectable drugs in Sweden. The company offers DrugLog, a solution for reducing medication errors in pharmacy; WasteLog, a device that analysis waste and returns of injectable controlled substances; and PrepLog, a DrugLog based technology platform that integrated prescription software or medication management system for the test of drug preparations. The company formerly known as Pharmacolog i Uppsala AB (publ) and changed its name to Perpetua Medical AB (publ) in April 2024.
Perpetua Medical AB (publ) Fundamentals Summary
| P750 fundamental statistics | |
|---|---|
| Market cap | €1.29m |
| Earnings (TTM) | -€1.05m |
| Revenue (TTM) | €578.73k |
2.2x
P/S Ratio-1.2x
P/E RatioIs P750 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| P750 income statement (TTM) | |
|---|---|
| Revenue | SEK 6.58m |
| Cost of Revenue | SEK 2.77m |
| Gross Profit | SEK 3.81m |
| Other Expenses | SEK 15.79m |
| Earnings | -SEK 11.98m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 23, 2024
| Earnings per share (EPS) | -0.11 |
| Gross Margin | 57.86% |
| Net Profit Margin | -182.05% |
| Debt/Equity Ratio | 0% |
How did P750 perform over the long term?
See historical performance and comparison